Goldman Sachs Group Inc Evotec Se Transaction History
Goldman Sachs Group Inc
- $580 Billion
- Q2 2024
A detailed history of Goldman Sachs Group Inc transactions in Evotec Se stock. As of the latest transaction made, Goldman Sachs Group Inc holds 64,856 shares of EVO stock, worth $231,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,856Holding current value
$231,535% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EVO
# of Institutions
29Shares Held
2.69MCall Options Held
0Put Options Held
0-
Wellington Management Group LLP Boston, MA2.03MShares$7.25 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny192KShares$683,7540.0% of portfolio
-
Morgan Stanley New York, NY122KShares$434,8610.0% of portfolio
-
Dcf Advisers, LLC Greenwich, CT115KShares$410,3820.3% of portfolio
-
Black Rock Inc. New York, NY82.6KShares$294,8740.0% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.26B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...